SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-17
👔
Alaunos Therapeutics, Inc.
@TCRT_InsiderForm 4 Filing: Weis Holger Acquires (Grant) $17,539.86 of $TCRT
STOCK AWARD / GRANT
⚡ MATERIALITY: 3/10
corporate issuer
Alaunos Therapeutics, Inc.
Ticker: $TCRT
Transaction Value
$17,539.86
Price/Share: $2.26
transaction date
2026-06-12
Shares: 7,761
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Weis Holger, holds the title of Chief Executive Officer at Alaunos Therapeutics, Inc..
On 2026-06-12, the insider transacted 7,761 shares.The shares were transacted at a weighted average price of $2.26 per share, resulting in a total market-relevant value of $17,539.86.
Executive Summary Summary
Weis Holger (Chief Executive Officer) was granted $18K of $TCRT
Post-Transaction Position: 12,672 shares
SEC Accession No: 0001193125-26-274305 (CIK: 1846984)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.